Related Experiment Video
Updated: Aug 1, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
[Expression of nuclear factor-kappaB in bone marrow cells from patients with acute leukemia and its relationship with
Hai-Yan Hu1, Hui Sun, Dian-Bin Zou
1Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Abstract:
To investigate the expression of NF-kappaB in acute leukemia and its relationship with P21, and matrix metalloproteinases (MMP), the expression of NF-kappaB, P21, MMP-2 and MMP-9 in bone marrow cells from patients with acute leukemia (AL) was detected using immunocytochemical technique. The results showed that the expression ratios of NF-kappaB, P21, MMP-2 and MMP-9 in untreated AL group were significantly higher than those in remission and normal control groups (P < 0.05), and no obvious difference was seen between remission and normal control groups. The expression of NF-kappaB was correlated with that of P21, MMP-2 and MMP-9 (r = 0.767, 0.729 and 0.803, respectively, P < 0.05). This study indicated that P21 protein, encoded by oncogene Ras, and NF-kappaB were super-expressed in leukemia cells. In conclusion, after activation by Ras, NF-kappaB combined with the kappaB sequences of MMP-2 and MMP-9 genes, then upregulated their expression. MMP might enhance the degradative function of leukemic cell, thus to make cells easier to cross through the bone marrow barrier and release into blood.
Insights
Nuclear factor-kappa B (NF-kappaB) and matrix metalloproteinases (MMPs) are overexpressed in acute leukemia (AL). This suggests NF-kappaB activation by Ras may drive AL progression by upregulating MMPs, facilitating leukemic cell invasion.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Context:
- Acute leukemia (AL) is a heterogeneous hematologic malignancy.
- The role of specific molecular pathways, such as NF-kappaB and MMPs, in AL pathogenesis requires further elucidation.
- Understanding these pathways could reveal novel therapeutic targets.
Purpose:
- To investigate the expression levels of NF-kappaB, P21, MMP-2, and MMP-9 in acute leukemia bone marrow cells.
- To determine the correlation between NF-kappaB expression and the expression of P21, MMP-2, and MMP-9 in AL.
- To explore the potential mechanism by which NF-kappaB influences MMP expression and leukemic cell behavior.
Summary:
- Immunocytochemical analysis revealed significantly higher expression of NF-kappaB, P21, MMP-2, and MMP-9 in untreated acute leukemia cells compared to remission and normal controls.
- A strong positive correlation was observed between NF-kappaB expression and the expression of P21, MMP-2, and MMP-9.
- Results indicate that Ras-activated NF-kappaB upregulates MMP-2 and MMP-9 gene expression, potentially enhancing leukemic cell invasiveness.
Impact:
- This study identifies NF-kappaB and MMPs as potential biomarkers for acute leukemia.
- The findings suggest that the Ras-NF-kappaB-MMP axis plays a critical role in leukemic cell migration and bone marrow barrier penetration.
- Targeting this pathway could offer a novel therapeutic strategy for managing acute leukemia.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation

